MedPage Today October 9, 2024
— But experts are skeptical the list would have much impact
The Centers for Medicare & Medicaid Services (CMS) on Wednesday issued a request for information on a proposed model program that would lower prices to $2 per month for certain generic drugs purchased through Medicare Part D drug plans, but experts expressed concerns about the potential uptake and usefulness of such a program.
The model is designed to provide individuals more certainty about the out-of-pocket costs for these generic Part D drugs for common conditions, such as high cholesterol and high blood pressure, CMS said in a press release.
“We want generic drugs for common chronic conditions to be affordable for people on Medicare. Reliably low copayments for essential...
Today's Sponsors
Today's Sponsor